References
Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K et al (2006) TWEAK is a novel arthritogenic mediator. J Immunol 177(4):2610–2620
Kamata K, Kamijo S, Nakajima A, Koyanagi A, Kurosawa H, Yagita H et al (2006) Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis. J Immunol 177(9):6433–6439
Brown SA, Richards CM, Hanscom HN, Feng SL, Winkles JA (2003) The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem J 371(Pt 2):395–403
Gyrd-Hansen M, Darding M, Miasari M, Santoro MM, Zender L, Xue W et al (2008) IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol 10(11):1309–1317
Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-Gracia JM et al (2004) CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 50(12):3866–3877
Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P et al (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. J Cell Biol 182(1):171–184
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grant from Liaoning educational office.
Rights and permissions
About this article
Cite this article
Xia, L., Shen, H., Lu, J. et al. TRAF2 and cIAP2 involve in TWEAK-induced MMP-9 production in fibroblast-like synoviocytes. Rheumatol Int 32, 281–282 (2012). https://doi.org/10.1007/s00296-010-1640-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1640-x